FIELD: biotechnology; genetic engineering.
SUBSTANCE: invention relates to recombinant plasmid DNA of the sgRNA(MS2)_zeo_Myc series. These plasmid DNAs encode a guide RNA sequence containing a 21 nucleotide long region complementary to the promoter region of the human Myc gene ensuring activation of the MYC gene in human cells. The invention also relates to a method of producing a monoclonal human breast cancer cell line BT549_Myc with stably increased expression of the Myc gene.
EFFECT: obtaining a human cell lines with overexpression of the Myc gene; the invention is also intended for research and development.
3 cl, 6 dwg, 4 ex
Title | Year | Author | Number |
---|---|---|---|
RECOMBINANT PLASMID DNAS PX458D10A_MYC, PROVIDING MYC GENE KNOCKOUT IN HUMAN CELLS, METHOD OF PRODUCING HUMAN CELL LINE WITH MYC GENE KNOCKOUT AND HUMAN BREAST CANCER CELL LINE MDA-MB231_MYC WITH SUPPRESSED MYC GENE EXPRESSION | 2022 |
|
RU2818348C1 |
MICROVESICLE AND METHOD FOR ITS PREPARATION | 2014 |
|
RU2693088C2 |
SYSTEM FOR ACTIVATING HUMAN APOBEC/AID CYTIDINE DEAMINASES AND/OR HUMAN URACIL-DNA-GLYCOSYLASE UNG AND ITS USE FOR ELIMINATING CCC DNA OF HEPATITIS B VIRUS FROM HUMAN CELLS, PARTICULARLY HEPATOCYTES | 2018 |
|
RU2703532C1 |
DOUBLE-STRANDED RNA CAPABLE OF REDUCING EXPRESSION OF MUTANT ALLELE C.607G>A OF HUMAN GNAO1 GENE | 2022 |
|
RU2816137C1 |
METHOD OF DETERMINING LEVEL OF CHIMERIC GENE Trim5a EXPRESSION | 2015 |
|
RU2592675C1 |
RECOMBINANT PLASMID pSM-ZsGreen, CODING HUMAN PROTEINS SOX2 AND C-MYC AND FLUORESCENT PROTEIN ZsGreen, INTENDED TO PRODUCE INDUCED PLURIPOTENT HUMAN STEM CELLS | 2011 |
|
RU2477314C1 |
SYSTEM FOR STIMULATION OF GENES EXPRESSION AND VECTOR CONTAINING SAID SYSTEM | 2010 |
|
RU2577971C2 |
NEW TRANSCRIPTION ACTIVATOR | 2019 |
|
RU2800921C2 |
IMPROVING GENETIC CONSTRUCTS FOR PROVIDING HIGH EFFICACY OF ANTI-HIV THERAPY | 2013 |
|
RU2533817C1 |
PSCA-CAR-YT CELL LINE HAVING SURFACE EXPRESSION OF CHIMERIC ANTIGEN RECEPTORS AND EXHIBITING CYTOTOXIC ACTIVITY ON PSCA-POSITIVE HUMAN CANCER CELLS | 2018 |
|
RU2712901C1 |
Authors
Dates
2024-02-06—Published
2022-12-23—Filed